Bakhu Holdings Reports $771K Net Loss and Declining Assets for Quarter Ending October 31, 2024

Bakhu Holdings, Corp. reported its financial results for the three months ending October 31, 2024, revealing a net loss of $771,387, a decrease from the net loss of $1,131,478 recorded in the same period last year. The company has not generated any revenue during this period, consistent with its historical performance. Total operating expenses for the quarter were $663,440, down from $1,067,367 in the prior year, primarily due to reduced consulting fees and professional expenses. The decrease in operating expenses reflects the company's ongoing efforts to manage costs amid its strategic focus on developing its cannabis-related business.

In terms of financial position, Bakhu Holdings reported total assets of $14,035 as of October 31, 2024, a significant decline from $25,461 at the end of July 2024. Current liabilities increased to $3,073,046 from $2,846,464, driven by higher accounts payable and accrued liabilities. The company's accumulated deficit has grown to $51,682,544, up from $50,911,157, indicating ongoing challenges in achieving profitability. The total stockholders' equity deficit also widened to $11,293,954 from $11,011,550, reflecting the cumulative losses over time.

Strategically, Bakhu Holdings has maintained its focus on the cannabis sector, having acquired a license from Cell Science Holding Ltd. in 2018 for the production of cannabinoids. However, the company’s subsidiary, CBD Biotech Inc., which was established to commercialize this technology, reported no active operations as of the latest filing. The company has also faced operational challenges, including a settlement agreement with VO Leasing Corp. regarding its laboratory facility, which it abandoned during the previous fiscal year, resulting in a loss on the disposal of fixed assets.

Operationally, Bakhu Holdings has not reported any significant changes in customer counts or user statistics, as it continues to develop its business model. The company’s employee headcount remains stable, with no new hires or layoffs disclosed in the filing. The company’s cash and cash equivalents decreased to $14,035 from $25,461, indicating a tightening liquidity position. The company has indicated that it anticipates further losses as it continues to develop its business, raising concerns about its ability to sustain operations in the long term.

Looking ahead, Bakhu Holdings has not provided specific forward-looking statements regarding revenue generation or operational milestones. However, the company remains committed to its strategic initiatives in the cannabis sector, despite the ongoing financial challenges. The management's focus on cost management and potential future product launches will be critical as the company navigates its path toward achieving operational viability and financial stability.